| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | NFKB|Nuclear factor NF-kappa-B|Nuclear factor NF-kappa-B p100 subunit|DNA-binding factor KBF2|Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2|Nfkb2|Nuclear factor NF-kappa-B p105 subunit|DNA-binding factor KBF1|EBP-1|NF-kappa-B1 p84/NF-kappa-B1 p98|Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1|Nfkb1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
mouse NFkB (Nuclear Factor Kappa B) is a molecular target commonly studied in epigenetics, signal transduction, and metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of NFkB is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of NFkB can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
NFkB (Nuclear Factor Kappa B) may also be referenced as NFKB, Nuclear factor NF-kappa-B, and Nuclear factor NF-kappa-B p100 subunit in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how NFkB relates to energy homeostasis, glucose and lipid metabolism, insulin sensitivity and endocrine regulation, and adipose–liver crosstalk in epigenetics, signal transduction, and metabolism research.
- Interpreting shifts in NFkB levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
NFkB has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with epigenetics, signal transduction, and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Sulfated polysaccharide from Apostichopus japonicus viscera exhibits anti-inflammatory properties in vitro and in vivo
IF: 7.7 Journal: International Journal of Biological Macromolecules Author: College of Chemical Enginering, Huaqiao University, Xiamen 362021, China. Cited Date: 2024-09-20
Xenotransplantation of Human Umbilical Mesenchymal Stromal Cells Derived from Wharton's Jelly Mitigates Mouse Amyotrophic Lateral Sclerosis
IF: 7.3 Journal: Stem Cell Research & Therapy Author: School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Cited Date: 2025-08-01
Unveiling the antitumor synergy between pazopanib and metformin on lung cancer through suppressing p-Akt/NF-κB/STAT3/PD-L1 signal pathway
IF: 6.9 Journal: Biomedicine & Pharmacotherapy Author: Pharmacology and Toxicology Department, Faculty of Pharmacy, Damanhour University, 22511,?Egypt; Faculty of Health Sciences Technology, Borg Al Arab Technological University, New Borg El Arab, Egypt. Cited Date: 2024-10-08
Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil
IF: 5.8 Journal: International Journal of Pharmaceutics Author: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt Cited Date: 2023-12-01
Engineering tanshinone-loaded, levan-biofunctionalized polycaprolactone nanofibers for treatment of skin cancer
IF: 5.8 Journal: International Journal of Pharmaceutics Author: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt Cited Date: 2023-09-22
Blocking Notch signalling reverses miR-155-mediated inflammation in allergic rhinitis
IF: 5.714 Journal: International Immunopharmacology Cited Date: 2023-02-17
Pristimerin Dampens Acetaminophen-Induced Hepatotoxicity; The Role of NF-κB/iNOS/COX-II/Cytokines, PI3K/AKT, and BAX/BCL-2/Caspase-3 Signaling Pathways
IF: 5.5 Journal: Pharmaceutics Author: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Cited Date: 2025-11-28
Novel PEGylated cholephytosomes for targeting fisetin to breast cancer: in vitro appraisal and in vivo antitumoral studies
IF: 5.4 Journal: Drug Delivery and Translational Research Author: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt Cited Date: 2023-09-08
Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice
IF: 4.8 Journal: International Immunopharmacology Author: Department of Pharmacognosy, Faculty of Pharmacy, Helwan University., Cairo 11795, Egypt. Cited Date: 2024-08-02
High‐Integrity Nanoformulation of Resiquimod (R848) for Dual Autophagy Activation and PD‐L1 Modulation in Triple‐Negative Breast Cancer
IF: 4.1 Journal: Macromolecular Bioscience Author: Biochemistry Division, Department of Chemistry, Faculty of Science, El Menoufia University, Shebin El-kom, Egypt. Cited Date: 2025-10-17
The reno-protective effect of Empagliflozin against carbon tetrachloride (CCl4)-induced nephrotoxicity in mice halting JNK/MKK4/NRF2/NF-KB pathway
IF: 3.9 Journal: Food and Chemical Toxicology